Analysis of hydrolyzable polyethylene glycol hydrogels and deproteinized bone mineral as delivery systems for glycosylated and non-glycosylated bone morphogenetic protein-2

Acta Biomaterialia

Volumn 8, Issue 1, 2012, Pages 116-123

  Hänseler, Patrick ^a   Jung, Ui Won ^c   Jung, Ronald E ^b   Choi, Kyoung Hee ^d   Cho, Kyoo Sung ^c   Hämmerle, Christoph H F ^b   Weber, Franz E ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Yonsei University College of Dentistry   (South Korea)

^d Research and Development Institute   (South Korea)

Author keywords

Bio Oss; Bone substitutes; Drug delivery system; Hydrogel; Recombinant rhBMP 2 protein

Indexed keywords

BIOACTIVITY; BONE; CELL CULTURE; CONTROLLED DRUG DELIVERY; PHOSPHATASES; POLYETHYLENE GLYCOLS; POLYETHYLENES; RECOMBINANT PROTEINS; TARGETED DRUG DELIVERY;

BIO-OSS; BONE MATRIX; BONE MORPHOGENETIC PROTEIN-2; BONE SUBSTITUTES; BOVINE BONE; DELIVERY SYSTEMS; DRUG-DELIVERY SYSTEMS; GLYCOSYLATED; HUMAN BONE MORPHOGENETIC PROTEIN; RECOMBINANT RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 PROTEIN;

HYDROGELS;

ALKALINE PHOSPHATASE; MACROGOL; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; BIOLOGICAL ACTIVITY; BONE MATRIX; BONE PROSTHESIS; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DELIVERY SYSTEM; ENZYME ASSAY; GLYCOSYLATION; HYDROGEL; IN VITRO STUDY; PRIORITY JOURNAL;

BOVINAE;

EID: 84855930190     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.08.002     Document Type: Article

References (39)

1. D.W. Sommerfeldt, and C.T. Rubin Biology of bone and how it orchestrates the form and function of the skeleton Eur Spine J 10 Suppl 2 2001 S86 S95
2. H.F. Sailer, and F.E. Weber Bone substitutes Mund Kiefer Gesichtschir 4 Suppl 1 2000 S384 S391
3. C.N. Cornell Osteobiologics Bull Hosp Jt Dis 62 2004 13 17 (Pubitemid 39381784)
4. P.V. Giannoudis, T.A. Einhorn, G. Schmidmaier, and D. Marsh The diamond concept-open questions Injury 39 Suppl 2 2008 S5 S8
5. M. Jager, B. Westhoff, A. Wild, and R. Krauspe Bone harvesting from the iliac crest Orthopade 34 2005 976 982 84, 86-90, 92-94
6. S.B. Nicoll Materials for bone graft substitutes and osseous tissue regeneration 2011 Springer Berlin
7. S. Sartori, M. Silvestri, F. Forni, A. Icaro Cornaglia, P. Tesei, and V. Cattaneo Ten-year follow-up in a maxillary sinus augmentation using anorganic bovine bone (Bio-Oss). A case report with histomorphometric evaluation Clin Oral Implants Res 14 2003 369 372 (Pubitemid 37465539)
8. M.R. Urist Bone: formation by autoinduction Science 150 1965 893 899
9. R.E. Jung, R. Glauser, P. Scharer, C.H. Hammerle, H.F. Sailer, and F.E. Weber Effect of rhBMP-2 on guided bone regeneration in humans Clin Oral Implants Res 14 2003 556 568
10. J.M. Wozney, V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, and R.W. Kriz Novel regulators of bone formation: molecular clones and activities Science 242 1988 1528 1534 (Pubitemid 19023695)
11. T.K. Sampath, J.C. Maliakal, P.V. Hauschka, W.K. Jones, H. Sasak, and R.F. Tucker Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro J Biol Chem 267 1992 20352 20362
12. B. Wildemann, N. Burkhardt, M. Luebberstedt, T. Vordemvenne, and G. Schmidmaier Proliferating and differentiating effects of three different growth factors on pluripotent mesenchymal cells and osteoblast like cells J Orthop Surg Res 2 2007 27
13. W.F. McKay, S.M. Peckham, and J.M. Badura A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft) Int Orthop 31 2007 729 734 (Pubitemid 350160311)
14. K. Bessho, Y. Konishi, S. Kaihara, K. Fujimura, Y. Okubo, and T. Iizuka Bone induction by Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2 Br J Oral Maxillofac Surg 38 2000 645 649 (Pubitemid 32051101)
15. J.H. Lee, C.S. Kim, K.H. Choi, U.W. Jung, J.H. Yun, and S.H. Choi The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli Biomaterials 31 2010 3512 3519
16. R. Ruppert, E. Hoffmann, and W. Sebald Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity Eur J Biochem 237 1996 295 302 (Pubitemid 26110301)
17. I.S. Kim, E.N. Lee, T.H. Cho, Y.M. Song, S.J. Hwang, and J.H. Oh Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2 Tissue Eng Part A 17 2011 337 348
18. T.J. Cho, L.C. Gerstenfeld, and T.A. Einhorn Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing J Bone Miner Res 17 2002 513 520 (Pubitemid 34171766)
19. K.V. Brown, B. Li, T. Guda, D.S. Perrien, S. Guelcher, and J.C. Wenke Improving bone formation in a rat femur segmental defect by controlling BMP-2 release Tissue Eng Part A 2011
20. T.J. Sigurdsson, L. Nygaard, D.N. Tatakis, E. Fu, T.J. Turek, and L. Jin Periodontal repair in dogs: evaluation of rhBMP-2 carriers Int J Periodontics Restorative Dent 16 1996 524 537
21. D.R. Hunt, S.A. Jovanovic, U.M. Wikesjo, J.M. Wozney, and G.W. Bernard Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study J Periodontol 72 2001 651 658 (Pubitemid 32479934)
22. C.S. Kim, J.I. Kim, J. Kim, S.H. Choi, J.K. Chai, and C.K. Kim Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers Biomaterials 26 2005 2501 2507 (Pubitemid 39600702)
23. S.J. Hong, C.S. Kim, D.K. Han, I.H. Cho, U.W. Jung, and S.H. Choi The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects Biomaterials 27 2006 3810 3816
24. U.W. Jung, S.Y. Choi, E.K. Pang, C.S. Kim, S.H. Choi, and K.S. Cho The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects J Periodontol 77 2006 765 772
25. R.E. Jung, C.H. Hammerle, V. Kokovic, and F.E. Weber Bone regeneration using a synthetic matrix containing a parathyroid hormone peptide combined with a grafting material Int J Oral Maxillofac Implants 22 2007 258 266
26. R.E. Jung, S.I. Windisch, A.M. Eggenschwiler, D.S. Thoma, F.E. Weber, and C.H. Hammerle A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2 Clin Oral Implants Res 20 2009 660 666
27. R.E. Jung, G. Lecloux, E. Rompen, C.F. Ramel, D. Buser, and C.H. Hammerle A feasibility study evaluating an in situ formed synthetic biodegradable membrane for guided bone regeneration in dogs Clin Oral Implants Res 20 2009 151 161
28. M. Herten, R.E. Jung, D. Ferrari, D. Rothamel, V. Golubovic, and A. Molenberg Biodegradation of different synthetic hydrogels made of polyethylene glycol hydrogel/RGD-peptide modifications: an immunohistochemical study in rats Clin Oral Implants Res 20 2009 116 125
29. D.S. Thoma, G.A. Halg, M.M. Dard, R. Seibl, C.H. Hammerle, and R.E. Jung Evaluation of a new biodegradable membrane to prevent gingival ingrowth into mandibular bone defects in minipigs Clin Oral Implants Res 20 2009 7 16
30. R.E. Jung, F.E. Weber, D.S. Thoma, M. Ehrbar, D.L. Cochran, and C.H. Hammerle Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate Clin Oral Implants Res 19 2008 188 195
31. D.L. Elbert, A.B. Pratt, M.P. Lutolf, S. Halstenberg, and J.A. Hubbell Protein delivery from materials formed by self-selective conjugate addition reactions J Control Release 76 2001 11 25 (Pubitemid 32786881)
32. R.E. Jung, G.A. Halg, D.S. Thoma, and C.H. Hammerle A randomized, controlled clinical trial to evaluate a new membrane for guided bone regeneration around dental implants Clin Oral Implants Res 20 2009 162 168
33. F.E. Weber, G. Eyrich, K.W. Gratz, F.E. Maly, and H.F. Sailer Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres Int J Oral Max Surg 31 2002 60 65
34. T. Katagiri, A. Yamaguchi, M. Komaki, E. Abe, N. Takahashi, and T. Ikeda Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage J Cell Biol 127 1994 1755 1766 (Pubitemid 24380911)
35. J. Hu, V. Duppatla, S. Harth, W. Schmitz, and W. Sebald Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues Bioconjug Chem 21 2010 1762 1772
36. M. Ehrbar, S.C. Rizzi, R.G. Schoenmakers, B.S. Miguel, J.A. Hubbell, and F.E. Weber Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions Biomacromolecules 8 2007 3000 3007 (Pubitemid 350011618)
37. T. Boix, J. Gomez-Morales, J. Torrent-Burgues, A. Monfort, P. Puigdomenech, and R. Rodriguez-Clemente Adsorption of recombinant human bone morphogenetic protein rhBMP-2m onto hydroxyapatite J Inorg Biochem 99 2005 1043 1050
38. G. Weibrich, R. Trettin, S.H. Gnoth, H. Gotz, H. Duschner, and W. Wagner Determining the size of the specific surface of bone substitutes with gas adsorption Mund Kiefer Gesichtschir 4 2000 148 152
39. N.R. Kubler, K.K. Wurzler, J.F. Reuther, E. Sieber, T. Kirchner, and W. Sebald Effect of different factors on the bone forming properties of recombinant BMPs Mund Kiefer Gesichtschir 4 Suppl 2 2000 S465 S469.